SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales
PARIS & BOULDER, Colo., April 17, 2024--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its full-year 2023 financial results, for the financial year ending December 31, 2023, as approved by the Board of Directors on April 17, 2024, and its first quarter 2024 sales.